A detailed history of Huntington National Bank transactions in Xencor Inc stock. As of the latest transaction made, Huntington National Bank holds 179 shares of XNCR stock, worth $3,388. This represents 0.0% of its overall portfolio holdings.

Number of Shares
179
Previous 111 61.26%
Holding current value
$3,388
Previous $2,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

BUY
$18.65 - $26.52 $1,268 - $1,803
68 Added 61.26%
179 $3,000
Q4 2023

Feb 07, 2024

BUY
$16.53 - $21.42 $1,834 - $2,377
111 New
111 $2,000
Q2 2023

Aug 11, 2023

BUY
$24.77 - $29.9 $3,294 - $3,976
133 New
133 $3,000

Others Institutions Holding XNCR

About Xencor Inc


  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.13B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Huntington National Bank Portfolio

Follow Huntington National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Huntington National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Huntington National Bank with notifications on news.